Effect of a Lipidic and Proteic Controlled Diet on Parkinson's Disease

University of Padova

Status: Unknown

Conditions: Parkinson Disease

Treatments: Other: Ketogenic diet

Study type: Interventional

Funder types: Other

Identifiers

NCT02687698

3575/AO/15

Details and patient eligibility

About

Parkinson's disease concerns some defects in carbohydrates metabolism involved in the progress of the pathology. Ketogenic diet has been largely studied as treatment on drug-resistant epilepsy and other neurologic diseases, but there is little information on the impact of this kind of diet in clinical aspects of Parkinson's disease. The aim of our study is thus to evaluate the effect of a lipid and protein controlled diet on resting energy expenditure, body composition and symptoms in patients with Parkinson's disease.

Full description

Parkinson's disease concerns some defects in carbohydrates metabolism involved in the progress of the pathology. Ketogenic diet has been largely studied as treatment on drug-resistant epilepsy and other neurologic diseases, but there is little information on the impact of this kind of diet in clinical aspects of Parkinson's disease. The aim of our study is thus to evaluate the effect of a lipid and protein controlled diet on resting energy expenditure, body composition and symptoms in Parkinson's disease patients.

Enrollment: 36 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with a diagnosis of Parkinson's disease, treated with L-Dopa or other dopaminergic drugs.
• Mini Mental State Examination (MMSE) >24.
• Activities of Daily Living >3.

Exclusion criteria

• Mini nutritional assessment <17; BMI <18, hypoalbuminemia or lymphopenia.
• acute or chronic liver diseases;
• renal function impairment (Clearance creatinine <30ml/min);
• cancer;
• acute inflammatory diseases;
• thyroid diseases;
• diabetes mellitus;
• dysphagia;
• dementia;
• dyslipidemia;
• history of recent cardiovascular or cerebrovascular events;
• psychiatric diseases;
• iatrogen parkinsonism.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

36 participants in 2 patient groups

Ketogenic diet

Experimental group

Description:

Patients will be suggested to follow a ketogenic diet for 8 weeks.

Treatment:

Other: Ketogenic diet

Control

No Intervention group

Description:

Usual diet.